Morgan Stanley’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Morgan Stanley’s Portfolio AUXL Stock Details AUXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-924,570	Closed	-$31.8M	–	6911
2014 Q4	$31.8M	Buy	924,570 +368,960	+66%	+$12M	0.01%	1133
2014 Q3	$16.6M	Buy	555,610 +36,617	+7%	+$776K	0.01%	1583
2014 Q2	$10.4M	Sell	518,993 -775	-0.1%	-$17.8K	﹤0.01%	2003
2014 Q1	$14.1M	Sell	519,768 -75,817	-13%	-$2.01M	0.01%	1674
2013 Q4	$12.3M	Sell	595,585 -236,105	-28%	-$4.45M	0.01%	1767
2013 Q3	$15.1M	Buy	831,690 +130,298	+19%	+$2.35M	0.01%	1450
2013 Q2	$11.7M	Buy	+701,392	New	+$11.2M	0.01%	1583

Other funds holding AUXL

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Morgan Stanley's AUXL Position: Q1 2015 in Review

Morgan Stanley sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 924,570 shares — an estimated $31.8M sold.

Morgan Stanley first reported a position in AUXL in Q2 2013 and held it in 7 quarters. The position peaked at $31.8M in Q4 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

Morgan Stanley reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
Morgan Stanley sold 924,570 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $31.8M.
Morgan Stanley first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 7 quarters.
Morgan Stanley's AUXILIUM PHARAMCEUTICALS INC position peaked at $31.8M in Q4 2014.
1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on Morgan Stanley's 13F filing for Q1 2015, filed 14 May 2015.